Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
As of today, Insmed Incorporated(INSM) shares are valued at $164.98. The company's market cap stands at 35.24B, with a P/E ratio of -25.54.
On 2026-04-01, Insmed Incorporated(INSM) stock moved within a range of $153.95 to $164.98. With shares now at $164.98, the stock is trading +7.2% above its intraday low and 0.0% below the session's peak.
Trading volume for Insmed Incorporated(INSM) stock has reached 3.67M, versus its average volume of 3.2M.
The stock's 52-week range extends from a low of $60.40 to a high of $212.75.
The stock's 52-week range extends from a low of $60.40 to a high of $212.75.
INSM News
Insmed (INSM) has attracted fresh attention after recent share price moves, with the stock up 5.5% over the past day and 10.2% over the past week, surpassing it...
Insmed INSM shares rallied 5.5% in the last trading session to close at $153.32. This move can be attributable to notable volume with a higher number of shares...
Morgan Stanley upgraded Insmed (INSM) to Overweight from Equal Weight with a price target of $212, up from $166. The firm says its survey suggests Brinsupri pre...
Analyst ratings
100%
of 21 ratingsMore INSM News
H.C. Wainwright raised the firm’s price target on Insmed (INSM) to $245 from $230 and keeps a Buy rating on the shares. Recently announced positive ENCORE data...
Insmed CEO reveals Japan patient population exceeds US market for lung disease By William Temple Published Mar 25, 10:58AM EDT Quick Read Insmed (INSM) announ...
If you are wondering whether Insmed at US$139.14 is priced for opportunity or already reflecting a lot of expectations, the starting point is to get very clear...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.